PMID: 16628286Apr 22, 2006Paper

Nationwide multicenter study on the prevalence of overweight and obesity in type 2 diabetes mellitus in the Brazilian population

Arquivos brasileiros de endocrinologia e metabologia
Marilia de Brito GomesSérgio Atala Dib

Abstract

To evaluate the prevalence of overweight and obesity in type 2 diabetic (DM2) outpatients from different regions of Brazil. We studied 2,519 randomly selected patients, from 11 hospitals, 2 endocrine and one general public care clinics from 10 cities. Overweight was defined as body-mass index (BMI) > 25 and obesity as BMI > 30 kg/m2. Glycemic control (GC) was evaluated by GC index (GCI = patient's HbA1 or HbA1c/upper limit of normal for the method x 100). 39% of the population studied was male, the mean age was 58.8 +/- 11.6 y, the duration from clinical diagnosis of DM2 was 9.0 +/- 7.3y, and BMI was 28.3 +/- 5.2 kg/m2. No measurements of BMI were recorded from 265 patients (10.5%). Patients from the Northeast presented lower BMI as compared with those from the Midwest, Southeast and South areas, respectively (26.4 +/- 4.7 vs. 27.9 +/- 4.8 vs. 29.2 +/- 5.1 vs. 29.4 +/- 5.4 kg/m2; p < 0.001). A greater prevalence of obesity was observed in the Southeast and South areas as compared to the Northeast (p < 0.001), as well as in the female group, respectively (69% vs. 31%; p < 0.001). Normal weight patients presented lower GCI. Patients being treated with two or more oral drugs and an association of insulin plus oral drug presented g...Continue Reading

References

May 1, 1994·American Journal of Public Health·R SichieriJ E Everhart
Dec 5, 1998·Diabetes Care·M B Davidson
Oct 8, 1999·The New England Journal of Medicine·E E CalleC W Heath
Feb 8, 2002·The New England Journal of Medicine·William C KnowlerUNKNOWN Diabetes Prevention Program Research Group
Mar 1, 2003·Diabetes Care·Pitiporn SuwatteeMerri L Pendergrass
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jan 22, 2004·JAMA : the Journal of the American Medical Association·Sharon H SaydahCatherine C Cowie
Jun 29, 2004·Diabetes Care·Jonathan B BrownAndrew Perry
Aug 18, 2004·Revista de saúde pública·Beatriz D'Agord SchaanIseu Gus
Apr 27, 2005·Lancet·Andrew G Renehan, Anthony Howell

❮ Previous
Next ❯

Citations

Oct 1, 2008·Cadernos de saúde pública·Malaquias Batista FilhoMarcela Carvalho dos Santos
Jan 23, 2008·Arquivos brasileiros de endocrinologia e metabologia·Ana Carolina J VasquesSilvia Eloiza Priore
May 29, 2008·Revista latino-americana de enfermagem·Idalina Diair Regla CarolinoRoberto Kenji Nakamura Cuman
Sep 5, 2015·Nutrients·Fabio MouraJeffrey I Mechanick
Jul 5, 2019·Journal of Cellular and Molecular Medicine·Xing XiaoYi Ma
Sep 12, 2014·Revista de saúde pública·Sheila Rizzato StopaMarilisa Berti de Azevedo Barros
Feb 22, 2012·Molecular Biology Reports·Mirelle O SóterMarinez O Sousa
Jul 27, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A Golay
Feb 2, 2021·Metabolic Syndrome and Related Disorders·Luciana de Brito Gonçalves NascimentoCarla Daltro
Sep 17, 2021·Diabetology & Metabolic Syndrome·Freddy G Eliaschewitz, Luis Henrique Canani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Metabolism: Clinical and Experimental
Gianluca BardiniStefano Giannini
Arquivos brasileiros de endocrinologia e metabologia
Gláucia Sarturi TresJorge Luiz Gross
Revista médica del Instituto Mexicano del Seguro Social
Enrique Villarreal-RíosMaría Guadalupe Hernández-Centeno
Revista médica del Instituto Mexicano del Seguro Social
Rafael Bustos-SaldañaGrupo de Estudio de Factores de Riesgo de Ulceraciones en los Pies de los Pacientes Diabéticos Tipo 2
© 2022 Meta ULC. All rights reserved